Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 263
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Pα+ Psychedelic Bulletin #206: Q2’25 Psychedelic Lobbying; Tabernanthalog’s Neuroplasticity Pathway; UK Moves to Ease Schedule I Research Restrictions
GLP-1 Drugs, Psilocybin Mushrooms, and the Case for Sublingual Psilocin
Therapy or Threat? UK Expert Warns of Rising Ketamine Addiction as Phase III Alcoholism Trial Launches
The Psychedelic News Feed: January 5 – June 1, 2025
Pα+ Psychedelic Bulletin #205: AbbVie Eyes Gilgamesh; Psychedelics Use Increases in U.S.; FDA Moves to Ban Kraton Compound 7-OH; What Is Sinema Selling?
Havn Life Sciences Signs LOI to Research and Develop Medical Psilocybin...
Psychedelic vs. Hallucinogen-What’s in a Name?
Psygen Industries Ltd. and Larose Ventures Ltd. Announce Reverse Takeover Transaction...
Psilocybin Data Study Agreement Reached Between Silo Wellness and Ehave Using...
Optimi Health Large Scale Multi-Purpose Mushroom Facility Advances Towards Completion and...
Numinus Deep Dive: Developing and Delivering Psychedelic-Assisted Psychotherapies
Mindset Pharma and InterVivo Solutions to Jointly Develop Advanced Cooperative Psychedelics...
COMPASS Pathways granted two US patents
Mydecine Innovations Group Announces Migration to NEO Exchange
PT236 – Dr. Carl Hart – Drugs: Honesty, Responsibility, and Logic
1
...
262
263
264
...
294
Page 263 of 294
